Board Meeting5 Nov 2026, 03:04 pm
Suraksha Diagnostic Board Meeting on Nov 10, 2026 for Q2 FY27 Results
AI Summary
Suraksha Diagnostic Ltd has announced that its Board of Directors will convene on November 10, 2026, to consider and approve the unaudited financial results for the quarter and half-year ended September 30, 2026. The meeting will take place at the company's registered office. Following this announcement, the trading window for company securities, which was closed from October 1, 2026, will reopen 48 hours after the financial results are declared. This information is also available on the company's website.
Key Highlights
- Board meeting scheduled for November 10, 2026.
- To approve unaudited financial results for Q2 FY27.
- Trading window to reopen 48 hours post results declaration.
- Financial results for the quarter and half-year ended September 30, 2026, will be discussed.
Price Impact
More from SURAKSHA